Screening for lung cancer

Chest Surgery Clinics of North America

Volumn 10, Issue 4, 2000, Pages 729-736

  Dominioni, L ^a   Strauss, G M ^a   Imperatori, A ^a   Rovera, F ^a   Dionigi, G ^a  

^a OSPEDALE DI CIRCOLO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; CANCER SURVIVAL; HEALTH CARE POLICY; HUMAN; LUNG CANCER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASS SCREENING; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RADIOGRAPHY, THORACIC; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033767747     PISSN: 10523359     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Report on the cancer-related health checkup: Cancer of the lung
2. Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: Are these carcinomas candidates for video-assisted lobectomy?
3. Consensus Statement: International conference on prevention and early diagnosis of lung cancer
4. Screening for lung cancer
5. The effect of surgical treatment on survival from early lung cancer: Implications for screening
6. Current status of screening for lung cancer
7. Lung cancer screening: The Mayo program
8. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: A national cancer data base report
9. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Lung Cancer Study Group
10. Stage I non-small cell lung cancer: A multivariate analysis of treatment method and patterns of recurrence
11. Early Lung Cancer Action Project: Overall design and findings from baseline screening
12. Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer: A randomized controlled trial
13. Wedge resection versus lobectomy for stage I (T1 NO M0) non-small cell lung cancer
14. Surgical Management: Stage I Disease (T1N0, T2N0)
15. Results of surgical treatment in stage I lung cancer
16. Factors influencing ten-year survival in resected stages I to IIIa non-small cell lung cancer
17. A new international staging system for lung cancer
18. Revisions in the international system for staging lung cancer
19. Implications of staging in lung cancer
20. Postsurgical stage I bronchogenic carcinoma: Morbid implications of recurrent disease
21. Global cancer statistics
22. Preventive Services Task Force (United States): Screening for lung cancer
23. Screening for lung cancer: Time to think positive
24. Survival for clinical stage I lung cancer not surgically treated
25. Mass screening for lung cancer with mobile spiral computed tomography scanner
26. Prognostic markers in resectable non-small cell carcinoma of the lung
27. The AtBCs of lung cancer screening
28. Screening for lung cancer: An evidence-based synthesis
29. Lung cancer screening and the surgical oncologist. The controversy
30. Screening for lung cancer: Another look; a different view
31. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small ceil lung cancer, stage I, II and IIIA
32. Time trends and survival after operations for primary lung cancer from 1976 through 1990
33. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. Five-years survival and patterns of intrathoracic recurrence
34. Surgical treatment of hilar and peripheral early NSCLC
35. Survival of patient surgically treated for stage I lung cancer